ISR Immune System Regulation Holding AB - Health Care Sector

A comprehensive view of ISR Immune System Regulation Holding AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gerresheimer signs agreement with drug development firm ISR for large-scale production of IcoOne nasal inhaler for ISR’s Phase 3 study of its dry powder COVID-19 vaccine; Gerresheimer has annual production capacity of more than 100 million inhalers

Published: June 02, 2022 by Gerresheimer AG

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count

CONTACT US

We offer built-to-order industry coverage for our clients. Click on any of the markets or drivers to see a sample intelligence map or call us for a free consultation.

Call Us

310.553.0008

Email Us

info@industryintel.com

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Latest Public Posts

Saving Our Planet with Lignocellulose

April 11, 2022

More Than One Reason That Gas Prices Are On The Rise

March 18, 2022

CEO reflects on 22 years of company growth and innovation, discusses vision of post-pandemic world

February 17, 2022

Useful Links

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

contact@industryintel.com
www.industryintel.com

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.